Arcturus Therapeutics Holdings Inc. (ARCT) shares are gaining on Monday morning, in spite of no announcement by the company to influence the stock.
Currently, the shares are at $52.50, up 6.34 percent from its previous close of $49.37. Shares have traded in a range of $8.51 to $66.24 on average volume of 688,600.
In early October, the clinical-stage messenger RNA medicines company had announced the completion of the first three dose escalation cohorts in its phase 1 study of ARCT-810 for Ornithine Transcarbamylase deficiency.
For comments and feedback contact: editorial@rttnews.com
